A study to implement a nurse driven protocol to increase pneumococcal conjugate and polysaccharide vaccination rate during a three month period among immunosuppressed patients
Latest Information Update: 13 Jan 2021
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- 13 Jan 2021 New trial record